Our findings suggest that subjects with elevated SP-D levels at baseline are more likely to develop T2DM than those with low SP-D levels, independent of traditional T2DM risk factors such as age, baseline fasting serum glucose level or BMI, among others. This evidence concerns the gene SFTPD and type 2 diabetes mellitus.